Author
Listed:
- Hugo Mouquet
(Laboratory of Molecular Immunology, The Rockefeller University)
- Johannes F. Scheid
(Laboratory of Molecular Immunology, The Rockefeller University
Charite Universitaetsmedizin)
- Markus J. Zoller
(Max Planck Institute for Infection Biology)
- Michelle Krogsgaard
(New York University School of Medicine)
- Rene G. Ott
(Laboratory of Molecular Genetics and Immunology, The Rockefeller University)
- Shetha Shukair
(Northwestern University)
- Maxim N. Artyomov
(Chemical Engineering, Biology, and Biological Engineering, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- John Pietzsch
(Laboratory of Molecular Immunology, The Rockefeller University
Institute of Chemistry and Biochemistry, Freie Universität Berlin)
- Mark Connors
(Laboratory of Immunoregulation, and Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health)
- Florencia Pereyra
(Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard Medical School)
- Bruce D. Walker
(Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard Medical School)
- David D. Ho
(Aaron Diamond AIDS Research Center)
- Patrick C. Wilson
(Section of Rheumatology, University of Chicago)
- Michael S. Seaman
(Beth Israel Deaconess Medical Center)
- Herman N. Eisen
(Chemical Engineering, Biology, and Biological Engineering, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Arup K. Chakraborty
(Chemical Engineering, Biology, and Biological Engineering, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology)
- Thomas J. Hope
(Northwestern University)
- Jeffrey V. Ravetch
(Laboratory of Molecular Genetics and Immunology, The Rockefeller University)
- Hedda Wardemann
(Max Planck Institute for Infection Biology)
- Michel C. Nussenzweig
(Laboratory of Molecular Immunology, The Rockefeller University
Howard Hughes Medical Institute, The Rockefeller University)
Abstract
Antibodies hedge their bets Most antibodies are highly specific, binding with high affinity to a single foreign antigen. However, an analysis of human immunodeficiency virus (HIV) envelope glycoprotein-specific monoclonal antibodies from infected subjects provides evidence for a surprisingly high degree of polyreactivity. Of 134 different antibodies directed at the gp140 envelope glycoprotein cloned from six patients, 75% were polyreactive, binding with high affinity to one gp140 site and with lower affinity to other sites on the viral surface. Relatively few gp140 glycoprotein spikes are displayed on the surface of HIV, so homotypic bivalent antibody binding is disfavoured and 'heteroligation' may help to improve net antibody affinity in such instances.
Suggested Citation
Hugo Mouquet & Johannes F. Scheid & Markus J. Zoller & Michelle Krogsgaard & Rene G. Ott & Shetha Shukair & Maxim N. Artyomov & John Pietzsch & Mark Connors & Florencia Pereyra & Bruce D. Walker & Dav, 2010.
"Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation,"
Nature, Nature, vol. 467(7315), pages 591-595, September.
Handle:
RePEc:nat:nature:v:467:y:2010:i:7315:d:10.1038_nature09385
DOI: 10.1038/nature09385
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:467:y:2010:i:7315:d:10.1038_nature09385. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.